Post-pandemic Era-Global Anti-Infective Drug Market 2024-2031, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 246394 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Anti-Infective Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Antibiotics -Product Introduction and Major Manufacturers
      1.1.2 Antivirals -Product Introduction and Major Manufacturers
      1.1.3 Antifungals -Product Introduction and Major Manufacturers
      1.1.4 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Anti-Infective Drug Status and Prospect (2015-2026)
      2.1.1 China Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.1.2 China Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Anti-Infective Drug Status and Prospect (2015-2026)
      2.2.1 EU Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.2.2 EU Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Anti-Infective Drug Status and Prospect (2015-2026)
      2.3.1 USA Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.3.2 USA Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Anti-Infective Drug Status and Prospect (2015-2026)
      2.4.1 Japan Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Anti-Infective Drug Status and Prospect (2015-2026)
      2.5.1 India Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.5.2 India Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Anti-Infective Drug Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Anti-Infective Drug Status and Prospect (2015-2026)
      2.7.1 South America Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.7.2 South America Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Anti-Infective Drug Status and Prospect (2015-2026)
      2.8.1  Anti-Infective Drug Market Size and Growth Rate (2015-2026)
      2.8.2  Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Anti-Infective Drug Market Assessment by Segment
    3.1 Global Anti-Infective Drug Capacity and Growth Rate
    3.2 Global Anti-Infective Drug Sales by Type
    3.3 Global Anti-Infective Drug Sales Revenue by Type
    3.4 Global Anti-Infective Drug Consumption by Application
4 Global Anti-Infective Drug Market Assessment by Regions
    4.1 Global Anti-Infective Drug Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Anti-Infective Drug Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Anti-Infective Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Anti-Infective Drug Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Anti-Infective Drug Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Anti-Infective Drug Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Anti-Infective Drug Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Anti-Infective Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Anti-Infective Drug Competitive Analysis
     7.1 Gilead Sciences
        7.1.1 Gilead Sciences Company Profiles
        7.1.2 Gilead Sciences Product Introduction
        7.1.3 Gilead Sciences Anti-Infective Drug Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Profiles
        7.2.2 GlaxoSmithKline Product Introduction
        7.2.3 GlaxoSmithKline Anti-Infective Drug Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Merck
        7.3.1 Merck Company Profiles
        7.3.2 Merck Product Introduction
        7.3.3 Merck Anti-Infective Drug Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Teva Pharmaceutical Industries
        7.4.1 Teva Pharmaceutical Industries Company Profiles
        7.4.2 Teva Pharmaceutical Industries Product Introduction
        7.4.3 Teva Pharmaceutical Industries Anti-Infective Drug Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Company Profiles
        7.5.2 Johnson & Johnson Product Introduction
        7.5.3 Johnson & Johnson Anti-Infective Drug Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Boehringer Ingelheim
        7.6.1 Boehringer Ingelheim Company Profiles
        7.6.2 Boehringer Ingelheim Product Introduction
        7.6.3 Boehringer Ingelheim Anti-Infective Drug Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Pfizer
        7.7.1 Pfizer Company Profiles
        7.7.2 Pfizer Product Introduction
        7.7.3 Pfizer Anti-Infective Drug Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Mylan N.V.
        7.8.1 Mylan N.V. Company Profiles
        7.8.2 Mylan N.V. Product Introduction
        7.8.3 Mylan N.V. Anti-Infective Drug Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Company Profiles
        7.9.2 Bristol-Myers Squibb Product Introduction
        7.9.3 Bristol-Myers Squibb Anti-Infective Drug Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 F. Hoffmann-La Roche
        7.10.1 F. Hoffmann-La Roche Company Profiles
        7.10.2 F. Hoffmann-La Roche Product Introduction
        7.10.3 F. Hoffmann-La Roche Anti-Infective Drug Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
     7.11 Shanghai Pharmaceuticals
8 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Anti-Infective Drug Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Anti-Infective Drug Sales (K Unit) by Type (2015-2026)
    Figure Global Anti-Infective Drug Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Anti-Infective Drug Sales Market Share (%) by Type (2019 -2020)
    Table Global Anti-Infective Drug Sales Value (Million USD) by Type (2015-2026)
    Figure Global Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Anti-Infective Drug Sales Value Market Share (%) by Type (2019-2020)
    Table Global Anti-Infective Drug Sales (K Unit) by Application (2015-2026)
    Figure China Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Anti-Infective Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Anti-Infective Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Anti-Infective Drug Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Anti-Infective Drug Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Anti-Infective Drug Sales (Unit) by Type (2015-2026)
    Figure Global Anti-Infective Drug Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Anti-Infective Drug Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Anti-Infective Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Anti-Infective Drug Consumption (Unit) by Application (2015-2026)
    Figure Global Anti-Infective Drug Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Anti-Infective Drug Production (K Unite) by Regions (2015-2020)
    Table Global Anti-Infective Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Anti-Infective Drug Production Share by Regions (2019-2020)
    Table Global Anti-Infective Drug Sales (K Unite) by Regions (2015-2020)
    Table Global Anti-Infective Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Anti-Infective Drug Sales Share by Regions (2019-2020)
    Table Global Anti-Infective Drug Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Anti-Infective Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Anti-Infective Drug Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Anti-Infective Drug
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Anti-Infective Drug
    Figure Cost Structure of Anti-Infective Drug in 2020
    Table Global Anti-Infective Drug Capacity Share of Manufacturers (2019-2020)
    Figure Global Anti-Infective Drug Capacity Share of Manufacturers (2019-2020)
    Table Global Anti-Infective Drug Sales Market Share of Manufacturers (2019-2020)
    Figure Global Anti-Infective Drug Sales Market Share of Manufacturers (2019-2020)
    Table Global Anti-Infective Drug Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Anti-Infective Drug Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Anti-Infective Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Gilead Sciences Profiles
    Table Gilead Sciences Anti-Infective Drug Product Introduction
    Table Gilead Sciences Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Gilead Sciences SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Anti-Infective Drug Product Introduction
    Table GlaxoSmithKline Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table Merck Profiles
    Table Merck Anti-Infective Drug Product Introduction
    Table Merck Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Merck SWOT Analysis
    Table Teva Pharmaceutical Industries Profiles
    Table Teva Pharmaceutical Industries Anti-Infective Drug Product Introduction
    Table Teva Pharmaceutical Industries Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Teva Pharmaceutical Industries SWOT Analysis
    Table Johnson & Johnson Profiles
    Table Johnson & Johnson Anti-Infective Drug Product Introduction
    Table Johnson & Johnson Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Johnson & Johnson SWOT Analysis
    Table Boehringer Ingelheim Profiles
    Table Boehringer Ingelheim Anti-Infective Drug Product Introduction
    Table Boehringer Ingelheim Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Boehringer Ingelheim SWOT Analysis
    Table Pfizer Profiles
    Table Pfizer Anti-Infective Drug Product Introduction
    Table Pfizer Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Pfizer SWOT Analysis
    Table Mylan N.V. Profiles
    Table Mylan N.V. Anti-Infective Drug Product Introduction
    Table Mylan N.V. Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Mylan N.V. SWOT Analysis
    Table Bristol-Myers Squibb Profiles
    Table Bristol-Myers Squibb Anti-Infective Drug Product Introduction
    Table Bristol-Myers Squibb Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Bristol-Myers Squibb SWOT Analysis
    Table F. Hoffmann-La Roche Profiles
    Table F. Hoffmann-La Roche Anti-Infective Drug Product Introduction
    Table F. Hoffmann-La Roche Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure F. Hoffmann-La Roche SWOT Analysis
    Table Shanghai Pharmaceuticals Profiles
    Table Shanghai Pharmaceuticals Anti-Infective Drug Product Introduction
    Table Shanghai Pharmaceuticals Anti-Infective Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Shanghai Pharmaceuticals SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Anti-Infective Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Anti-Infective Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Anti-Infective Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports